Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.62p
   
  • Change Today:
    -0.15p
  • 52 Week High: 3.96
  • 52 Week Low: 1.22
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 21,140,996
  • Market Cap: £21.68m
  • RiskGrade: 340

Regulatory News

Appointment of Medical Director 10-Aug-2022 07:00 RNS
Second Price Monitoring Extn 09-Aug-2022 14:06 RNS
Price Monitoring Extension 09-Aug-2022 14:00 RNS
New Custom R&D Facility Opening 13-Jul-2022 07:00 RNS
Investor Webinar Recording 08-Jul-2022 12:25 RNS
Change of Registered Office 01-Jul-2022 12:19 RNS
Result of Annual General Meeting 30-Jun-2022 15:29 RNS
Investor Webinar 27-Jun-2022 07:00 RNS
Posting of Annual Report & Notice of AGM 07-Jun-2022 14:17 RNS
Director/PDMR Shareholding 30-May-2022 07:00 RNS
Second Price Monitoring Extn 27-May-2022 14:05 RNS
Price Monitoring Extension 27-May-2022 14:00 RNS
Immuno-Oncology Summit Europe Presentation 16-May-2022 07:00 RNS
Final Results for the Year Ended 31 December 2021 29-Apr-2022 17:39 RNS
Second Price Monitoring Extn 21-Mar-2022 16:42 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.62p
Change Today -0.15p
% Change -8.44 %
52 Week High 3.96
52 Week Low 1.22
Volume 21,140,996
Shares Issued 1,341.82m
Market Cap £21.68m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.93% below the market average49.93% below the market average49.93% below the market average49.93% below the market average49.93% below the market average
67.35% below the sector average67.35% below the sector average67.35% below the sector average67.35% below the sector average67.35% below the sector average
Price Trend
27.29% below the market average27.29% below the market average27.29% below the market average27.29% below the market average27.29% below the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 27-Sep-2024

Time Volume / Share Price
17:07 650,420 @ 1.62p
16:28 159,125 @ 1.62p
16:19 68,052 @ 1.62p
16:14 70,000 @ 1.67p
16:03 11,594 @ 1.62p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page